Clinical Trial Update: BK With VST for Kidney Transplant Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating virus-specific T cells (VST) for BK virus infection in kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Infection

Drugs mentioned

• Virus-specific T cells (VST) (virus-specific T cells)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Kidney Transplant Infection, BK Virus Infection | Phase 1 | Status: COMPLETED